# Deepinder Goyal defends Temple wearable after doctors call it a scam 2026-11-05T23:56:50+00:00 | Technology | Indian Opinion Desk Corroboration: 4 independent outlets Deepinder Goyal on Thursday, 5 November defended his brain-monitoring wearable Temple, calling it a fitness tracker not a medical device, after doctors on X questioned its scientific basis. Goyal said he had spent $30m building Temple, including $20m of his own money, and that a 14-day no-questions-asked return policy proves the product is not a scam. Goyal added that he left his role as Eternal CEO to focus on Temple and that ‘pre-prints’ of validation studies are coming. Critics, including hepatologist Dr Cyriac Abby Philips, said the device only tracks blood flow in a superficial facial artery, not the brain. Temple is priced at Rs 85,000, with deliveries starting in early 2027. ## Indian Opinion Analysis All four outlets carry Deepinder Goyal’s identical seven-point X thread verbatim, making this uniform coverage of his defence. Business Today, NDTV Profit and Inc42 report his statements with no added critical framing, while Siasat includes the medical experts’ reactions, notably Dr Cyriac Abby Philips calling Goyal’s reply ‘word salad’. The outlets differ only in what they lead with: Business Today opens on the $30m spend, NDTV Profit on Goyal’s hint of undisclosed features, Inc42 on the pre-order price and shipping timeline, and Siasat on the device being a fitness tracker not a medical device. The factual core is common: Goyal insists Temple is not a scam, cites $20m of his own money, a 14-day return policy and imminent pre-prints. The added criticism from doctors appears only in Siasat and Inc42, making those reports more complete on the controversy. Goyal’s 5 November posts are the sole source of all statements attributed to him across the coverage. ## Coverage Coverage: 4 sources, 4 neutral - businesstoday.in (neutral report) Leads with Goyal’s defence and personal investment figure, no critical framing. - ndtvprofit.com (neutral report) Leads with Goyal’s rebuttal and cites his hint at unreleased features. - inc42.com (neutral report) Includes both Goyal’s defence and doctors’ criticism, notes pre-order details. - siasat.com (neutral report) Frames Goyal’s reply as ‘word salad’, prominently features doctor scepticism. This brief was synthesised by AI from the 4 sources linked above, so one read covers every framing they carry. Update, 6 November 2026: this story now draws on 4 sources. Last updated 2026-11-06T02:37:55+00:00. Tags: Deepinder Goyal, Dr Cyriac Abby Philips, Livertox, temple, Zomato Canonical: https://indianopinion.org/deepinder-goyal-defends-temple-amid-doctors-fraud-allegations/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/deepinder-goyal-defends-temple-amid-doctors-fraud-allegations/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/